Skip to main Content

Board of Directors

BNB Plus Corp’s Board of Directors consists of individuals with proven leadership skills, broad management experience in established companies, and their reputation as independent thinkers.
With experience in fields ranging from Bioagriculture to Zoology, the company will continue to benefit from the Board’s diversity of experience and opinions.

Josh Kruger Chairman of the BOD
Josh Kruger

Joshua Kruger served as Head of Trading & Portfolio Manager at DNA Asset Management (2024), where he directed a multi-strategy liquid token portfolio integrating systematic regime models, discretionary thematic allocations, and market-neutral positioning. Prior, he was Partner & Head of Trading at Coral Capital (2022), managing over $100M in AUM across DeFi market neutral and venture strategies before the firm’s acquisition by DNA in 2024. A recognized expert in protocol economics, he served as Lead Architect for Tokenomics & Game Theory at Tea Protocol (2023), working alongside Max Howell to optimize decentralized open-source contribution networks through sophisticated protocol incentive design. His entrepreneurial journey in digital assets began with co-founding OnChain Alpha (2020), a hedge fund focused on delta-neutral DeFi opportunities that was acquired by Coral Capital in 2022, and Kruger Pasch Capital (2017), which pioneered algorithmic funding strategies denominated in Bitcoin. In parallel with his work in digital assets, Kruger founded and supports a growing network of public charter schools in Puerto Rico that provide rigorous college preparatory education and expanded opportunity to underserved communities. He holds a B.S. in Computer Science with a specialization in Cybersecurity from Texas A&M University, combining deep technical expertise with quantitative finance acumen to navigate the evolving digital asset landscape.

Judith Murrah Director
Judith Murrah

Ms. Murrah joined the Board in June 2025. Prior to her appointment, she held several senior leadership positions within the Company, including Chief Operating Officer and Chief Executive Officer. Earlier in her career, Ms. Murrah served as Senior Director of Information Technology at Motorola Solutions following its acquisition of Symbol Technologies. During her tenure at Symbol, she advanced through a range of leadership roles encompassing product line management, global account sales, corporate and marketing communications, and information technology.

Ms. Murrah earned her MBA from Harvard Business School and a B.S. in Industrial Engineering from the University of Rhode Island. She is also the named inventor on 14 U.S. patents.

Robert B. Catell Director | Audit Committee Member
Robert B. Catell

Bob Catell joined the Board of Directors in October 2016. He has been a member of Applied DNA’s Strategic Advisory Council since February 2016.

Chairman New York State Smart Grid Consortium, Chairman, U.S., Advanced Energy Research and Technology Center at Stony Brook, Former Chairman of National Grid U.S., and former Chairman and CEO of KeySpan Corporation.

Joseph D. Ceccoli Director | Audit and Compensation Committees Member
Joseph D. Ceccoli

Compensation Committee Member
Audit Committee Member

Joseph Ceccoli joined the Board of Directors in December 2014.
Mr. Ceccoli is Founder, President and CEO of Biocogent, LLC, a bioscience company, focused on the invention, development and commercialization of skin-active molecules and treatment, and consumer products sold globally in 15 countries. Prior to founding Biocogent, Joe was Global Director of Operations for BASF Corporation, the world’s largest global chemical company, where he was responsible for the integration and operations of domestic and overseas business units. Earlier, Joe was a General Manager for Engelhard Corporation, a US-based Fortune 500 company.
Joe holds a Bachelor of Science degree in Biotechnology from the Rochester Institute of Technology and has received advanced professional training in various pharmaceutical sciences, emulsion chemistry, engineering and management disciplines. He is a member of numerous professional organizations.

Elizabeth M. Schmalz Shaheen Director | Compensation and Nominating Committees Member
Elizabeth M. Schmalz Shaheen

Elizabeth Schmalz Ferguson joined the Board of Directors, effective June 1, 2017.
An innovator in the cosmetics and fragrance industry, Ms. Ferguson started her senior management career at Revlon with responsibility for new product development for companies including Borghese, Ultima II, and Prestige fragrances. Later, as Senior Vice President of Corporate Product Development at Estée Lauder, her responsibilities included overseeing product development for some of the company’s most prominent brands. Subsequently, she was Executive Vice President of Product Development at Bath and Body Works and Victoria’s Secret for The Limited. She currently serves as President of American Flavors & Fragrances, a fragrance company, and President of her own consulting firm, Betsy Schmalz Ferguson & Associates. She is an active member of Cosmetic Executive Women. She earned a bachelor’s degree in psychology from Georgian Court University.

Dr. Yacov Shamash Chair of Compensation, Nominating, and Audit Committees
Dr. Yacov Shamash

Dr. Yacov Shamash has served on the Board of Directors since March 2006.

Dr. Shamash is Vice President for Economic Development at the State University of New York at Stony Brook. Since 1992, he has been the Dean of the College of Engineering and Applied Sciences at the University, and Founder of the New York State Center for Excellence in Wireless Technologies (CEWIT) and The Advanced Energy Research & Technology Center (AERTC) at the University. Dr. Shamash developed and directed the NSF Industry/University Cooperative Research Center for the Design of Analog/Digital Integrated Circuits from 1989 to 1992 and also served as Chairman of the Electrical and Computer Engineering Department at Washington State University from 1985 until 1992. Dr. Shamash also serves on the Board of Directors of Key Tronic Corporation.